Abstract
The octapeptide angiotensin II (Ang II) plays a homeostatic role in the regulation of blood pressure and water and electrolyte
balance, and also contributes to the progression of cardiovascular remodeling. Ang II activates Ang II type 1 (AT
Keywords: Angiotensin II, mechanical stress, receptor dimerization, renin-angiotensin system, signal transduction.
Current Pharmaceutical Design
Title:Angiotensin II Type 1 and Type 2 Receptor-induced Cell Signaling
Volume: 19 Issue: 17
Author(s): Hiroshi Akazawa, Masamichi Yano, Chizuru Yabumoto, Yoko Kudo-Sakamoto and Issei Komuro
Affiliation:
Keywords: Angiotensin II, mechanical stress, receptor dimerization, renin-angiotensin system, signal transduction.
Abstract: The octapeptide angiotensin II (Ang II) plays a homeostatic role in the regulation of blood pressure and water and electrolyte
balance, and also contributes to the progression of cardiovascular remodeling. Ang II activates Ang II type 1 (AT
Export Options
About this article
Cite this article as:
Akazawa Hiroshi, Yano Masamichi, Yabumoto Chizuru, Kudo-Sakamoto Yoko and Komuro Issei, Angiotensin II Type 1 and Type 2 Receptor-induced Cell Signaling, Current Pharmaceutical Design 2013; 19 (17) . https://dx.doi.org/10.2174/1381612811319170003
DOI https://dx.doi.org/10.2174/1381612811319170003 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
PPARγ: Potential Therapeutic Target for Ailments Beyond Diabetes and its Natural Agonism
Current Drug Targets Ca2+ Signalling in Damaged Endothelium: Do Connexin Hemichannels Aid in Filling the Gap?
Current Drug Therapy Role of miRNAs in Coronary Artery Disease
Current Signal Transduction Therapy Has Selenium a Chemopreventive Effect on Hepatocellular Carcinoma?
Mini-Reviews in Medicinal Chemistry Experimental Antioxidant Biotherapy for Protection of the Vascular Wall by Modified Forms of Superoxide Dismutase and Catalase
Current Pharmaceutical Design Importance of Aquaporins in the Physiopathology of Brain Edema
Current Pharmaceutical Design Non-transfusion Dependent Thalassemias: A Developing Country Perspective
Current Pediatric Reviews Chemical Connexin Impairment in the Developing Gonad Associated with Offspring Infertility
Current Medicinal Chemistry Targeting Small Arteries of Hypertensive Status with Novel ATP-Sensitive Potassium Channel Openers&#
Current Vascular Pharmacology Crohns Targeted Therapy: Myth or Real Goal?
Current Drug Discovery Technologies Mitochondrial Proteases as Emerging Pharmacological Targets
Current Pharmaceutical Design Proteomic Analysis of the Kidney in Rat Biliary Cirrhosis
Current Proteomics New Analytical Tools for Studying Autoimmune Diseases
Current Pharmaceutical Design Kidney in Diabetes: from Organ Damage Target to Therapeutic Target
Current Drug Metabolism Effects of Hypoxia and Ischemia on MicroRNAs in the Brain
Current Medicinal Chemistry Bone Marrow Mesenchymal Stem Cells: Agents of Immunomodulation and Neuroprotection
Current Stem Cell Research & Therapy Signs and Related Mechanisms of Ethanol Hepatotoxicity
Current Drug Abuse Reviews Cardiopulmonary Interactions in Children with Heart Failure
Current Cardiology Reviews Impact of Antihypertensive Drug Use on Bone Mineral Density and Osteoporotic Fracture - From an Epidemiological Perspective
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Medical Management and Risk Reduction of the Cardiovascular Effects of Underwater Diving
Current Vascular Pharmacology